A groundbreaking study reveals that insulin resistance, measured by the triglyceride-glucose (TyG) index, can be a crucial indicator of rapid cognitive decline in Alzheimer's patients. Those with higher TyG levels face a fourfold increase in deterioration rates, prompting new intervention strategies.
A groundbreaking study suggests that daytime napping may significantly increase the risk of premature death. Researchers tracked the sleep habits of over 86,000 adults, revealing alarming links between frequent napping and mortality.
The music world mourns the loss of Brian Wilson, the Beach Boys co-founder, who passed away at 82. John Stamos recounts the heartbreaking moment he shared with Mike Love after hearing the news.
A groundbreaking study reveals that where you live in the U.S. could significantly impact your risk of developing dementia. Discover the shocking regional disparities in brain health and what they mean for you.
A groundbreaking study reveals that following the MIND diet can significantly lower the risk of Alzheimer's and related dementias. Discover how adopting healthier eating habits can benefit brain health at any age!
Discover the poignant story of Garland Jeffreys, the 'most promising artist' whose unique blend of rock and race commentary shaped a generation, yet remained largely unrecognized. This new documentary explores his life, struggles, and music.
A groundbreaking study reveals that adhering to the MIND diet can significantly reduce the risk of Alzheimer's and related dementias, with the greatest benefits seen in African American, Latino, and White participants. Discover how dietary improvements can lead to better cognitive health!
Starting late June, a groundbreaking blood test designed to diagnose Alzheimer’s disease will be available in the U.S., offering a faster and more cost-effective alternative to traditional methods. This innovation could revolutionize Alzheimer’s treatment and improve patient outcomes!
The FDA has approved Lumipulse, the first blood test for diagnosing Alzheimer’s, offering a simpler and less invasive option compared to traditional methods like PET scans. Experts believe this could revolutionize care and research.
The FDA has approved the first blood test for Alzheimer's, allowing for earlier diagnosis and treatment with existing drugs. This groundbreaking development could significantly impact millions facing cognitive decline.
